New York, July 07, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Digital Therapeutics Industry" - https://www.reportlinker.com/p05798376/?utm_source=GNW
B2B, one of the segments analyzed in the report, is projected to record 29.6% CAGR and reach US$30.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the B2c segment is readjusted to a revised 19.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.7 Billion, While China is Forecast to Grow at 31.8% CAGR
The Digital Therapeutics market in the U.S. is estimated at US$1.7 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 31.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 25.2% and 23.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 28.7% CAGR.
Select Competitors (Total 136 Featured)
- AstraZeneca PLC
- 2Morrow, Inc.
- Click Therapeutics, Inc.
- Canary Health Inc.
- Adherium (NZ) Limited
- AppliedVR, Inc.
- Cognoa, Inc.
- Amiko Digital Health Limited
- Atentiv LLC
- CureApp, Inc.
- Biofourmis
- Behaivior
- BehaVR
- Aidar Health
- Cara Care
Read the full report: https://www.reportlinker.com/p05798376/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Digital Therapeutics is Poised to Benefit from the Increasingly
Robust Outlook for Digital Health
Digital Healthcare Sets the Stage for the Rise of Digital
Therapeutics: Global Market for Digital Health (In US$
Billion) for Years 2023, 2025, and 2027
Global Economic Update
Shaken by the War, Global Oil Prices Spiral and Feed
Inflationary Pressures, Guiding the World Towards a Cost of
Living Crisis: Global Average Annual Brent Crude Oil Price
(In US$ Per Barrel) for Years 2017 through 2024
War-Induced Commodity Price Increases & Broad Based Price
Pressures Mark the Return of Global Inflation to the Highest
Level Seen Since 1996: Global Inflation Rates (In %) for the
Years 2019 Through 2024
Although Facing a Lower Recession Risk, Global Economic Growth
in 2023 to Slowdown Amid War, Inflation, Elevated Interest
Rates & Marginal Easing of Inflation: World Economic Growth
Projections (Real GDP, Annual % Change) for the Years 2020
Through 2024
Recession Triggered by Uncontrolled Inflation or Unemployment,
Which is the Greater Evil? Inflation Battling Policy Measures
to Slowdown Post Pandemic Recovery in Unemployment Rates:
Global Number of Unemployed People (In Million) for Years
2019 Through 2024
Competition
Digital Therapeutics - Global Key Competitors Percentage Market
Share in 2023 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2023 (E)
Digital Therapeutics: Overview & Market Outlook
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
3. MARKET TRENDS & DRIVERS
Shockingly High Burden of Mental Disorders & the Ensuing Focus
to Meet Unmet Care Needs Primes Digital Therapeutics for Mass
Adoption: Global Economic Cost of Mental Illnesses (In US$
Trillion) for Years 2023, 2025, 2027, 2029 & 2031
Artificial Intelligence to Play a Key Role in Improving the
Effectiveness of Digital Therapeutics
High Prevalence of Chronic Diseases and Growing Focus Long-Term
Management & Preventative Healthcare Widens Growth
Opportunities
Rising Prevalence of Chronic Diseases Amplifies the Need for
Addressing Management of These Diseases Through Digital
Therapeutics: Global Cost of Chronic Diseases (In US$
Trillion) for the Years 2023, 2025, 2027, 2029 and 2031
Here?s How Digital Therapeutics Can Help Improve Clinical
Outcomes Across the Cardiac Continuum
Global Annual Medical Cost of Cardiovascular Diseases in US$
Billion (2010-2030)
How Digital Therapeutics is Changing the Oncology Care Landscape?
Worrisome Epidemic Increase in Cancer Incidence to Help
Accelerate Adoption of Digital Therapeutics: Global Cancer
Incidence: Number of New Cancer Cases in Million for the
Years 2018, 2020, 2025, 2030, 2035 and 2040
Rise of mHealth & Smart Medical Devices & Wearables Paves the
Way for More Spontaneous Adoption of Digital Therapeutics
Growing Familiarity with mHealth & Use of Medical Wearables
Means There is One Less Obstacle in the Implementation of
Digital Therapeutics: Global Market for mHealth & Medical
Wearables (In US$ Billion) for Years 2023, 2025, 2027, 2029
and 20231
As Healthcare Costs Continue to Spiral, Growing Much Faster
Than National GDP, Focus Shifts to Digital Therapeutics for
its Ability to Lower Cost of Care
Growing Urgency to Rein-in Spiraling Healthcare Costs Leads
Healthcare Community to Take a Closer Look at Digital
Therapeutics: Healthcare Costs as a % of GDP by Country 2020
VS 2023
Growing Preference for Personalized Medicine Doubles the Focus
on Digital Therapeutics
Robust Outlook for Personalized Medicine to Create a Parallel
Opportunity for Digital Therapeutics: Global Market for
Personalized Medicines (In US$ Billion) for Years 2023 2025,
2027, 2029 and 2031
Here?s How AR/VR Technologies are Changing the Future of
Digital Therapeutics
The Many Benefits of 5G in Healthcare to Catalyze Adoption of
Digital Therapeutics
Rapid Penetration of 5G Will Make Implementation of Digital
Therapeutics Seamless & More Efficient to Use: Global 5G
Subscription (In Million) for Years 2023, 2025, 2027 and 2029
Technology and Innovation to Continue to Drive Adoption of
Digital Therapeutics
Cybersecurity Storms Into the Spotlight. Here?s Why
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Digital Therapeutics Market Analysis of Annual
Sales in US$ Thousand for Years 2022 through 2030
Table 2: World Recent Past, Current & Future Analysis for
Digital Therapeutics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR
Table 3: World 8-Year Perspective for Digital Therapeutics by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for B2B
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2022 through 2030
and % CAGR
Table 5: World 8-Year Perspective for B2B by Geographic Region -
Percentage Breakdown of Value Revenues for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030
Table 6: World Recent Past, Current & Future Analysis for B2C
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Revenues in US$ Thousand for Years 2022 through 2030
and % CAGR
Table 7: World 8-Year Perspective for B2C by Geographic Region -
Percentage Breakdown of Value Revenues for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030
Table 8: World Recent Past, Current & Future Analysis for
Treatment / Care by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Revenues in US$ Thousand for
Years 2022 through 2030 and % CAGR
Table 9: World 8-Year Perspective for Treatment / Care by
Geographic Region - Percentage Breakdown of Value Revenues for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for
Preventive by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Revenues in US$ Thousand for Years 2022
through 2030 and % CAGR
Table 11: World 8-Year Perspective for Preventive by Geographic
Region - Percentage Breakdown of Value Revenues for USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
for Years 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
Digital Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 12: USA Recent Past, Current & Future Analysis for
Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 13: USA 8-Year Perspective for Digital Therapeutics by
Sales Channel - Percentage Breakdown of Value Revenues for B2B
and B2C for the Years 2023 & 2030
Table 14: USA Recent Past, Current & Future Analysis for
Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 15: USA 8-Year Perspective for Digital Therapeutics by
Application - Percentage Breakdown of Value Revenues for
Treatment / Care and Preventive for the Years 2023 & 2030
CANADA
Table 16: Canada Recent Past, Current & Future Analysis for
Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 17: Canada 8-Year Perspective for Digital Therapeutics by
Sales Channel - Percentage Breakdown of Value Revenues for B2B
and B2C for the Years 2023 & 2030
Table 18: Canada Recent Past, Current & Future Analysis for
Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 19: Canada 8-Year Perspective for Digital Therapeutics by
Application - Percentage Breakdown of Value Revenues for
Treatment / Care and Preventive for the Years 2023 & 2030
JAPAN
Table 20: Japan Recent Past, Current & Future Analysis for
Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 21: Japan 8-Year Perspective for Digital Therapeutics by
Sales Channel - Percentage Breakdown of Value Revenues for B2B
and B2C for the Years 2023 & 2030
Table 22: Japan Recent Past, Current & Future Analysis for
Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 23: Japan 8-Year Perspective for Digital Therapeutics by
Application - Percentage Breakdown of Value Revenues for
Treatment / Care and Preventive for the Years 2023 & 2030
CHINA
Table 24: China Recent Past, Current & Future Analysis for
Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 25: China 8-Year Perspective for Digital Therapeutics by
Sales Channel - Percentage Breakdown of Value Revenues for B2B
and B2C for the Years 2023 & 2030
Table 26: China Recent Past, Current & Future Analysis for
Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 27: China 8-Year Perspective for Digital Therapeutics by
Application - Percentage Breakdown of Value Revenues for
Treatment / Care and Preventive for the Years 2023 & 2030
EUROPE
Digital Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 28: Europe Recent Past, Current & Future Analysis for
Digital Therapeutics by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Revenues in US$ Thousand for Years 2022 through 2030 and
% CAGR
Table 29: Europe 8-Year Perspective for Digital Therapeutics by
Geographic Region - Percentage Breakdown of Value Revenues for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2023 & 2030
Table 30: Europe Recent Past, Current & Future Analysis for
Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 31: Europe 8-Year Perspective for Digital Therapeutics by
Sales Channel - Percentage Breakdown of Value Revenues for B2B
and B2C for the Years 2023 & 2030
Table 32: Europe Recent Past, Current & Future Analysis for
Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 33: Europe 8-Year Perspective for Digital Therapeutics by
Application - Percentage Breakdown of Value Revenues for
Treatment / Care and Preventive for the Years 2023 & 2030
FRANCE
Table 34: France Recent Past, Current & Future Analysis for
Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 35: France 8-Year Perspective for Digital Therapeutics by
Sales Channel - Percentage Breakdown of Value Revenues for B2B
and B2C for the Years 2023 & 2030
Table 36: France Recent Past, Current & Future Analysis for
Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 37: France 8-Year Perspective for Digital Therapeutics by
Application - Percentage Breakdown of Value Revenues for
Treatment / Care and Preventive for the Years 2023 & 2030
GERMANY
Table 38: Germany Recent Past, Current & Future Analysis for
Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 39: Germany 8-Year Perspective for Digital Therapeutics
by Sales Channel - Percentage Breakdown of Value Revenues for
B2B and B2C for the Years 2023 & 2030
Table 40: Germany Recent Past, Current & Future Analysis for
Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 41: Germany 8-Year Perspective for Digital Therapeutics
by Application - Percentage Breakdown of Value Revenues for
Treatment / Care and Preventive for the Years 2023 & 2030
ITALY
Table 42: Italy Recent Past, Current & Future Analysis for
Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 43: Italy 8-Year Perspective for Digital Therapeutics by
Sales Channel - Percentage Breakdown of Value Revenues for B2B
and B2C for the Years 2023 & 2030
Table 44: Italy Recent Past, Current & Future Analysis for
Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 45: Italy 8-Year Perspective for Digital Therapeutics by
Application - Percentage Breakdown of Value Revenues for
Treatment / Care and Preventive for the Years 2023 & 2030
UNITED KINGDOM
Table 46: UK Recent Past, Current & Future Analysis for Digital
Therapeutics by Sales Channel - B2B and B2C - Independent
Analysis of Annual Revenues in US$ Thousand for the Years 2022
through 2030 and % CAGR
Table 47: UK 8-Year Perspective for Digital Therapeutics by
Sales Channel - Percentage Breakdown of Value Revenues for B2B
and B2C for the Years 2023 & 2030
Table 48: UK Recent Past, Current & Future Analysis for Digital
Therapeutics by Application - Treatment / Care and Preventive -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 49: UK 8-Year Perspective for Digital Therapeutics by
Application - Percentage Breakdown of Value Revenues for
Treatment / Care and Preventive for the Years 2023 & 2030
REST OF EUROPE
Table 50: Rest of Europe Recent Past, Current & Future Analysis
for Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 51: Rest of Europe 8-Year Perspective for Digital
Therapeutics by Sales Channel - Percentage Breakdown of Value
Revenues for B2B and B2C for the Years 2023 & 2030
Table 52: Rest of Europe Recent Past, Current & Future Analysis
for Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 53: Rest of Europe 8-Year Perspective for Digital
Therapeutics by Application - Percentage Breakdown of Value
Revenues for Treatment / Care and Preventive for the Years 2023 &
2030
ASIA-PACIFIC
Digital Therapeutics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 54: Asia-Pacific Recent Past, Current & Future Analysis
for Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 55: Asia-Pacific 8-Year Perspective for Digital
Therapeutics by Sales Channel - Percentage Breakdown of Value
Revenues for B2B and B2C for the Years 2023 & 2030
Table 56: Asia-Pacific Recent Past, Current & Future Analysis
for Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 57: Asia-Pacific 8-Year Perspective for Digital
Therapeutics by Application - Percentage Breakdown of Value
Revenues for Treatment / Care and Preventive for the Years 2023 &
2030
REST OF WORLD
Table 58: Rest of World Recent Past, Current & Future Analysis
for Digital Therapeutics by Sales Channel - B2B and B2C -
Independent Analysis of Annual Revenues in US$ Thousand for the
Years 2022 through 2030 and % CAGR
Table 59: Rest of World 8-Year Perspective for Digital
Therapeutics by Sales Channel - Percentage Breakdown of Value
Revenues for B2B and B2C for the Years 2023 & 2030
Table 60: Rest of World Recent Past, Current & Future Analysis
for Digital Therapeutics by Application - Treatment / Care and
Preventive - Independent Analysis of Annual Revenues in US$
Thousand for the Years 2022 through 2030 and % CAGR
Table 61: Rest of World 8-Year Perspective for Digital
Therapeutics by Application - Percentage Breakdown of Value
Revenues for Treatment / Care and Preventive for the Years 2023 &
2030
IV. COMPETITION
Read the full report: https://www.reportlinker.com/p05798376/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
